Microcide Pharmaceuticals (MCDE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Microcide Pharmaceuticals (MCDE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (140)	2/5/1998 12:36:00 AM
From: Larry Liebman	of 186

In the "Why not at this price?" mode, I returned to MCDE at the close, to the tune of 7 9/16. I re-read the H&Q report from 12/2/97 where they issued a "buy" at $10+, and the 9/97 "strong buy" from Cowen at $13+. The stock is roughly 50% of its IPO in 1996, while having made significant progress in its R&D in the interim. From talking with a company rep. it was clear that they are "motivated" to move their first antibiotic into the clinic this year. He also stated that they have significant interest from large pharma in their fungal program. I don't profess to know when MCDE will rise again, however with a market cap of <$85 million, and 1/2 of that in cash, in an area with a worldwide market of $23 billion, MCDE seems worthy of consideration. I assume the risk-reward to be quite favorable at this level.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next